EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses

Janina Burk iD, Liza Wittenberg-Voges, Susanna Schubert iD, Carolin Horstmeier, Walter Brehm, Florian Geburek iD

Cells · 24.10.2023 · 12 (21) · 2513

DOI: 10.3390/cells12212513 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cells, online erschienen am 24.10.2023. Verfasst von Janina Burk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, Pathophysiology and Biophysics, University of Veterinary Medicine Vienna, Veterinaerplatz 1, 1210 Vienna, Austria. Hauptthemen laut MEDLINE: Reinjuries, Horse Diseases, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University of Veterinary Medicine Hannover, Foundation, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of tendinopathies with multipotent mesenchymal stromal cells (MSCs) is a promising option in equine and human medicine. However, conclusive clinical evidence is lacking. The purpose of this study was to gain insight into clinical treatment efficacy and to identify suitable outcome measures for larger clinical studies. Fifteen horses with early naturally occurring tendon disease were assigned to intralesional treatment with allogeneic adipose-derived MSCs suspended in serum or with serum alone through block randomization (dosage adapted to lesion size). Clinicians and horse owners remained blinded to the treatment during 12 months (seven horses per group) and 18 months (seven MSC-group and five control-group horses) of follow-up including clinical examinations and diagnostic imaging. Clinical inflammation, lameness, and ultrasonography scores improved more over time in the MSC group. The lameness score difference significantly improved in the MSC group compared with the control group after 6 months. In the MSC group, five out of the seven horses were free of re-injuries and back to training until 12 and 18 months. In the control group, three out of the seven horses were free of re-injuries until 12 months. These results suggest that MSCs are effective for the treatment of early-phase tendon disease and provide a basis for a larger controlled study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReinjuriesHorse DiseasesMesenchymal Stem Cell TransplantationMesenchymal Stem CellsHematopoietic Stem Cell TransplantationHumansHorsesAnimalsPilot ProjectsLameness, AnimalTendons

Stichwörter der Autor:innen

MSCadiposeclinical studyhorse serummesenchymal progenitor cellsmesenchymal stem cellsre-injuryrecurrence ratetendinopathytendon lesion

Autor:innen und Institutionen

  • Institute of Physiology, Pathophysiology and Biophysics, University of Veterinary Medicine Vienna, Veterinaerplatz 1, 1210 Vienna, Austria.
  • Clinic for Horses, University of Veterinary Medicine Hannover, Foundation, Bünteweg 9, 30559 Hannover, Germany.
  • Institute of Human Genetics, University of Leipzig Medical Center, Philipp-Rosenthal-Strasse 55, 04103 Leipzig, Germany.
  • Department for Horses, Veterinary Teaching Hospital, University of Leipzig, An den Tierkliniken 21, 04103 Leipzig, Germany.

ORCID-Profile: Janina Burk, Susanna Schubert, Florian Geburek

Förderung

  • Deutsche Forschungsgemeinschaft
  • University of Veterinary Medicine Hannover, Foundation
  • German Research Foundation

Zitieren

APA

Burk, J., Wittenberg-Voges, L., Schubert, S., Horstmeier, C., Brehm, W., & Geburek, F. (2023). Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Cells, 12(21), 2513. https://doi.org/10.3390/cells12212513

Vancouver

Burk J, Wittenberg-Voges L, Schubert S, Horstmeier C, Brehm W, Geburek F. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Cells. 2023;12(21):2513. doi:10.3390/cells12212513

BibTeX
@article{Burk2023,
  author = {Burk, Janina and Wittenberg-Voges, Liza and Schubert, Susanna and Horstmeier, Carolin and Brehm, Walter and Geburek, Florian},
  title = {Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {21},
  pages = {2513},
  doi = {10.3390/cells12212513}
}
Kostenlos starten →